https://pubmed.ncbi.nlm.nih.gov/34430430/

Transl Pediatr. 2021 Jul;10(7):1825-1833.
doi: 10.21037/tp-21-103.
PEX26 gene genotype-phenotype correlation in neonates with Zellweger syndrome

Yue He 1, Sam Bill Lin 1, Wen-Xuan Li 1, Lin Yang 2, Rong Zhang 1, Chao Chen 1, Lin Yuan 1

Abstract
Background: Zellweger syndrome (ZS) is commonly manifested as facial deformities, hypotonia, and liver dysfunction. However, ZS caused by PEX26 gene mutation shows a broad and dispersed clinical pattern. In this study, the PEX26 gene in ZS was analyzed to enrich its clinical characteristics. Meanwhile, phenotypic and genotypic characteristics of Zellweger spectrum disorder (ZSD) induced by PEX26 mutation were evaluated.

Methods: The clinical data of newborn with ZS in our hospital were analyzed retrospectively. We performed WES and found that the infant carried the PEX26 gene variant. We searched the biomedical literature databases (PubMed, Web of Science, and EMBASE) to compare clinical features and genotypes.

Results: The neonate developed facial deformities, hypotonia, feeding difficulties, and seizures. Her homozygous variant was found in the PEX26 gene (NM_017929: exon2: c.34del) inherited from both parents. Electronic databases, including our case, reported 32 pathogenic variants in PEX26. We found that variation c.292C> T accounted for the largest proportion of PEX26 mutations (16/66, 24.24%). The proportion of deleterious mutations in ZS patients was significantly higher than that in NALD and IRD patients.
Conclusions: We identified pathogenic variations in the PEX26 gene and expanded the known mutant spectrum. By comparing patients with PEX26 mutations, the study determined that a significantly higher percentage of deleterious mutations in ZS was associated with severe clinical phenotypic characteristics.

Published on: 
Aug-2021

CLF Intro movie

Financial Aid Offered by Trusts

Follow us on: